Sage Journals: Discover world-class research

Open access

Review article

First published 2019

Clinically relevant drug interactions with multikinase inhibitors: a review

Koen G. A. M. Hussaarts, G. D. Marijn Veerman, Frank G. A. Jansman [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2018-1

Lenvatinib – A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer

Yvonne Hewett, Subash Ghimire, Bilal Farooqi [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2025-10

Neoadjuvant Therapy with Multikinase Inhibitors for Locally Advanced Differentiated Thyroid Cancer: A Systematic Review

Justin Bauzon, Guillermo Ponce de Leon-Ballesteros, Eddy Lincango [...]

Thyroid®

Retricted access

Research article

First published 2007-03

Renal Cell Cancer and Sorafenib: Skin Toxicity and Treatment Outcome

Emilio Bajetta, Giuseppe Procopio, Elena Verzoni [...]

Tumori Journal

Retricted access

Research article

First published 2022-09

Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)

Marcia S. Brose, Johannes W.A. Smit, Chia-Chi Lin [...]

Thyroid®

Retricted access

Abstract

First published 2007-3

Attenuation of a Rodent Model of Pulmonary Hypertension: A Novel Role for Sorafenib,a Multikinase Inhibitor

A.A. Desai, L. Moreno, M.M. Gomberg-Maitland [...]

Journal of Investigative Medicine

Retricted access

Research article

First published 2021-6

How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs

Jiexiu Chen, Zhuo Wang

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2022

RET kinase inhibitors for RET -altered thyroid cancers

Danica M. Vodopivec, Mimi I. Hu

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2022-11

Multikinase Inhibitors (MKIs) in the Treatment of Radioactive Iodine–Refractory (RAIR) Differentiated Thyroid Cancer

Kenneth D. Burman

Clinical Thyroidology®

Retricted access

Research article

First published 2026-1

Neoadjuvant Multikinase Inhibitor Therapy for Locally Advanced and Unresectable Differentiated Thyroid Cancer Shows Promise

Marika D. Russell

Clinical Thyroidology®

Search results